U S PHYSICAL THERAPY INC /NV Amortization of Debt Issuance Costs
U S PHYSICAL THERAPY INC /NV (USPH) reported Amortization of Debt Issuance Costs of $212.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for the quarter ending 2026-06-30 was $107.00K, a 2.88% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for the quarter ending 2026-03-31 was $105.00K, a 0.94% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for the quarter ending 2025-12-31 was $107.00K, a 1.90% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for the quarter ending 2025-09-30 was $105.00K, a 1.87% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for fiscal 2025 was $422.00K, a 0.00% change from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for fiscal 2024 was $422.00K, a 0.48% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for fiscal 2023 was $420.00K, a 37.70% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV amortization of debt issuance costs for fiscal 2022 was $305.00K, a 444.64% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $212.00K 10-Q · filed 2026-08-07 | $319.00K derived: sum of 3 quarters · filed 2026-08-07 | $424.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $105.00K 10-Q · filed 2026-05-08 | $212.00K derived: sum of 2 quarters · filed 2026-05-08 | $317.00K derived: sum of 3 quarters · filed 2026-05-08 | $421.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $212.00K derived: sum of 2 quarters · filed 2026-02-27 | $316.00K derived: sum of 3 quarters · filed 2026-08-07 | $422.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $209.00K derived: sum of 2 quarters · filed 2026-08-07 | $315.00K 10-Q · filed 2025-11-07 | $420.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $210.00K 10-Q · filed 2026-08-07 | $315.00K derived: sum of 3 quarters · filed 2026-08-07 | $422.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $106.00K 10-Q · filed 2026-05-08 | $211.00K derived: sum of 2 quarters · filed 2026-05-08 | $318.00K derived: sum of 3 quarters · filed 2026-05-08 | $422.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $212.00K derived: sum of 2 quarters · filed 2026-02-27 | $316.00K derived: sum of 3 quarters · filed 2026-02-27 | $422.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $211.00K derived: sum of 2 quarters · filed 2025-11-07 | $317.00K 10-Q · filed 2025-11-07 | $422.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $210.00K 10-Q · filed 2025-08-08 | $315.00K derived: sum of 3 quarters · filed 2026-02-27 | $420.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $106.00K 10-Q · filed 2025-05-09 | $211.00K derived: sum of 2 quarters · filed 2026-02-27 | $316.00K derived: sum of 3 quarters · filed 2026-02-27 | $420.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $210.00K derived: sum of 2 quarters · filed 2026-02-27 | $314.00K derived: sum of 3 quarters · filed 2026-02-27 | $420.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $105.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $209.00K derived: sum of 2 quarters · filed 2024-11-08 | $315.00K 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $210.00K 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | $106.00K 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $305.00K 10-K · filed 2025-03-03 | |||
| 2021-12-31 | $56.00K 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |